Influenza Session Robert L. Atmar, MD Chair, Influenza Work Group - PowerPoint PPT Presentation

Aug 29, 2023 •384 likes •445 views

Influenza Session Robert L. Atmar, MD Chair, Influenza Work Group Advisory Committee on Immunization Practices February 24, 2020 Influenza Work Group ACIP Members Liaison Representatives Robert Atmar (Chair) Sarah Coles (AAFP) Kevin Ault

Influenza Session Robert L. Atmar, MD Chair, Influenza Work Group Advisory Committee on Immunization Practices February 24, 2020
Influenza Work Group ACIP Members Liaison Representatives Robert Atmar (Chair) Sarah Coles (AAFP) Kevin Ault Buddy Creech (PIDS) Hank Bernstein Sarah Despres (Consumer Representative) Peter Szilagyi Sandra Fryhofer (ACP; AMA) Keipp Talbot Ian Gemmill (NACI) Denise Jamieson (ACOG) Ex Officio Members Marie-Michèle Léger (AAPA) Michael Cooper (NIH) Susan Lett (CSTE) Cynthia Nolletti (FDA) Flor Munoz (AAP) Chris Roberts (NIH) William Schaffner (NFID) Susan Wollersheim (FDA) Rob Schechter (AIM) Ken Schmader (AGS) Consultants Patsy Stinchfield (NAPNAP) Ed Belongia Tamara Sheffield (AHIP) Jeff Duchin Kelsey Young (NACI) Wendy Keitel Matthew Zahn (NACCHO) Jamie Loehr Mark Mulligan Kathy Neuzil
Recap of Influenza Session, October 2019  Overview of early 2019-20 season influenza activity  Presentation from Sanofi Pasteur of pre-licensure study of quadrivalent high-dose inactivated influenza vaccine, Fluzone High-Dose Quadrivalent – Subsequently licensed by FDA November 4, 2019  Discussion of planned systematic review of influenza vaccines for older adults
Recent Work Group Discussion  Presentation and discussion of preliminary safety results from a comparative study of adjuvanted and high-dose inactivated vaccines among persons 65 years of age and older  Presentation from Seqirus of pre-licensure study of quadrivalent adjuvanted inactivated influenza vaccine, Fluad Quadrivalent – Licensed by FDA February 21, 2020  Selection of efficacy/effectiveness and safety outcomes for review of influenza vaccines for older adults
Agenda Overview  Older Adult (65+) Adjuvanted Quadrivalent Influenza Vaccine (aIIV4) Phase III Trial Dr. Gregg Sylvester (Seqirus) –  2019-20 U.S. Influenza Surveillance Update Ms. Lynnette Brammer, CDC/NCIRD –  Interim Estimates of 2019–20 Seasonal Influenza Vaccine Effectiveness against Medically Attended Influenza from the US Flu VE Network Dr. Brendan Flannery, CDC/NCIRD –  Safety of Adjuvanted vs. High-Dose Inactivated Influenza Vaccines in Older Adults: Preliminary Safety Results Dr. Kenneth Schmader, Duke University Medical Center –  Summary and Work Group Considerations Dr. Lisa Grohskopf, CDC/NCIRD –

Recommend

2009 Influenza Update Influenza Facts Influenza Disease Protection, Treatment and

10/20/2009 Influenza Update 2009 Influenza Update Influenza Facts Influenza Disease Protection, Treatment and Medical Care Community Mitigation Rebecca Ward, BS Rich Lakin, MSPH, MPA Questions and Answers Resources

75 views • 5 slides

Influenza Tim Uyeki MD, MPH, MPP, FAAP Influenza Division National Center for Immunization and

Influenza Tim Uyeki MD, MPH, MPP, FAAP Influenza Division National Center for Immunization and Respiratory Diseases Coordinating Center for Infectious Diseases Centers for Disease Control and Prevention August 7, 2006 Influenza Influenza

664 views • 42 slides

Influenza vaccines Cheryl Cohen cherylc@nicd.ac.za Overview Burden of influenza and risk

Influenza vaccines Cheryl Cohen cherylc@nicd.ac.za Overview Burden of influenza and risk groups Clinical presentation, diagnosis and treatment Influenza the virus Currently available influenza vaccines Vaccine production

1.22k views • 58 slides

Nothing to disclose. Influenza Update Lisa Winston, MD UCSF / San Francisco General Hospital

12/15/2014 Nothing to disclose. Influenza Update Lisa Winston, MD UCSF / San Francisco General Hospital Divisions of Infectious Diseases and Hospital Medicine Influenza Biology Influenza Biology Influenza A Influenza viruses are single

301 views • 10 slides

The A(H7N9) influenza outbreak in China Anne Kelso Director WHO Collaborating Centre for

Viruses in May, Katoomba, 9 11 May 2013 The A(H7N9) influenza outbreak in China Anne Kelso Director WHO Collaborating Centre for Reference and Research on Influenza Melbourne Influenza in the 21 st century: why do we worry? Influenza in the

489 views • 45 slides

Swine Influenza Dr Paba Palihawadana Chief Epidemiologist Swine Influenza Respiratory

Swine Influenza Dr Paba Palihawadana Chief Epidemiologist Swine Influenza Respiratory disease of pigs Caused by type A influenza viruses Humans do not normally get Rarly human infections can occur Swine flu viruses have been

379 views • 7 slides

THE IMPORTANCE OF THE INFLUENZA VACCINE Education for All Staff Symptoms of Influenza Fever

THE IMPORTANCE OF THE INFLUENZA VACCINE Education for All Staff Symptoms of Influenza Fever or feeling feverish/chills Cough Sore throat Runny or stuffy nose Muscle or body aches Headaches Fatigue (tiredness) Some

466 views • 27 slides

Franciscan Alliance Mandatory Workforce Influenza Vaccination Program Why a Mandatory Influenza

Franciscan Alliance Mandatory Workforce Influenza Vaccination Program Why a Mandatory Influenza Vaccination Program? Healthcare Facility leaders must answer these questions: 1. Are influenza vaccines safe and effective in HCWs? 2. Do any

420 views • 19 slides

References References References Abbate R, Di Giuseppe G, Marinelli P, et al. Knowledge,

Influenza & Avian Influenza Influenza & Avian Influenza References References References Abbate R, Di Giuseppe G, Marinelli P, et al. Knowledge, attitudes, and practices of avian influenza, poultry workers, Italy. Emerg Infect Dis 2006

816 views • 25 slides

Influenza Immunisation Programme past and present Presentation to the 4 th New Zealand

Influenza Immunisation Programme past and present Presentation to the 4 th New Zealand Influenza Sym posium 8 February 20 18 Diana Murfitt, Senior Advisor, Ministry of Health Ov erv iew 1. Policy direction 2. Influenza Programme over the

321 views • 19 slides

Influenza Vaccination Rosalyn Singleton, MD Amy Groom, MPH Background American

Influenza Vaccination Rosalyn Singleton, MD Amy Groom, MPH Background American Indian/Alaska Native (AI/AN) people are at higher risk for influenza- related complications compared to U.S. Whites: Pneumonia and influenza-related

394 views • 28 slides

1918 INFLUENZA PROJECT TODAY The cemetery The influenza epidemic The project

KARORI CEMETERY 1918 INFLUENZA PROJECT TODAY The cemetery The influenza epidemic The project Walkabout THE CEMETERY 1891-1965 100 acres (40 hectares) c 85,000 interments 3 heritage listed structures 2 national

571 views • 21 slides

SHIVERS Southern Hemisphere Influenza and Vaccine Effectiveness Research and Surveillance

SHIVERS Southern Hemisphere Influenza and Vaccine Effectiveness Research and Surveillance Nikki Turner Feb 2012 Aims Robust estimation of the protective effect of seasonal influenza vaccine in the prevention of: Hospitalised influenza

227 views • 19 slides

Gressingham Foods PHWG REGIONAL WORKSHOP ON AVIAN INFLUENZA The impact of Avian Influenza ( UK

Gressingham Foods PHWG REGIONAL WORKSHOP ON AVIAN INFLUENZA The impact of Avian Influenza ( UK and Global) 9/11/2015 Dr Andrew Ballantyne Senior Commercial Farms Manager Green Label Poultry Ltd Gressingham Foods, Loomswood Farm, Debach,

319 views • 31 slides

INFLUENZA UPDATE: 2013-2014 Lawrence D. Frenkel, MD, FAAP (aka Larry) THE ANNUAL INFLUENZA

9/13/2013 INFLUENZA UPDATE: 2013-2014 Lawrence D. Frenkel, MD, FAAP (aka Larry) THE ANNUAL INFLUENZA EPIDEMICS CAUSED BY NEW STRAINS REMAIN A HUGE CHALLENGE FOR ALL OF US 1 9/13/2013 Issues Is egg allergy a real contraindication?

388 views • 13 slides

Influenza, 2017-18 Board of Health Monthly Meeting February 14, 2018 Jenifer Leaf Jaeger, MD,

Influenza, 2017-18 Board of Health Monthly Meeting February 14, 2018 Jenifer Leaf Jaeger, MD, MPH Interim Medical Director Influenza by the Numbers Annual Influenza-Related Illnesses in the United States, 2010-2016 9.2 - 35.6 million

419 views • 20 slides

for Influenza in Swine OFFLU Swine Influenza Group 2009 pH1N1 Lessons Learned Media, fear,

Coordinating Global Surveillance for Influenza in Swine OFFLU Swine Influenza Group 2009 pH1N1 Lessons Learned Media, fear, trade, politics, etc., often ignored the science Geographic and host origins of virus unclear Gaps in

428 views • 19 slides

2020 Symposia Series 1 Weighing the Options: Prevention and Management of Influenza in Patients

2020 Symposia Series 1 Weighing the Options: Prevention and Management of Influenza in Patients at High Risk for Complications Learning Objectives Identify available and emerging options for prevention of influenza Select influenza

547 views • 41 slides

2020 Symposia Series 2 Weighing the Options: Prevention and Management of Influenza in Patients

2020 Symposia Series 2 Weighing the Options: Prevention and Management of Influenza in Patients at High Risk for Complications Learning Objectives Identify available and emerging options for prevention of influenza Select influenza

441 views • 41 slides

Surveillance of Avian Influenza in Animals FETP Avian Influenza Training Photo by Dr. Sue Trock

Surveillance of Avian Influenza in Animals FETP Avian Influenza Training Photo by Dr. Sue Trock Learning Objectives Describe surveillance methods for avian influenza in birds and other animals Describe the difference in surveillance

615 views • 23 slides

Shoo the Flu Influenza Summit September 17, 2014 San Leandro Whatever you do, don t get the

Shoo the Flu Influenza Summit September 17, 2014 San Leandro Whatever you do, don t get the FLU! Influenza negatively impacts the health and well- being of children, adults, and the elderly. Wed like to get rid of flu in our community.

291 views • 15 slides

INFLUENZA 2018 & 2019 Seasonal Influenza Campaigns Main Components Blue dust branding

INFLUENZA 2018 & 2019 Seasonal Influenza Campaigns Main Components Blue dust branding evolving over several years Resources reviewed annually and updated as required Develop additional resources as budget allows Branding,

512 views • 28 slides

Northland DHB Influenza Vaccination Rates What are we doing right? Case Study: Running an

Northland DHB Influenza Vaccination Rates What are we doing right? Case Study: Running an effective influenza campaign with emphasis on preparation, communication, reporting and collaboration February 2018 Introduction This presentation

541 views • 27 slides

SPANISH INFLUENZA in one room, especially for sleeping is attack is soon over, and there

Researching influenza. 1. Overcrowding in dwellings The wisest course when attacked is to go to and in unventilated rooms and places of bed, keep warm, take light nourishing entertainment should be avoided. 2. The food, and report to your

195 views • 6 slides